ISOLATEFIBROMYALGIA Trademark

Trademark Overview

On Monday, May 1, 2017, a trademark application was filed for ISOLATEFIBROMYALGIA with the United States Patent and Trademark Office. The USPTO has given the ISOLATEFIBROMYALGIA trademark a serial number of 87432305. The federal status of this trademark filing is REGISTERED as of Tuesday, June 12, 2018. This trademark is owned by IQuity Labs, Inc.. The ISOLATEFIBROMYALGIA trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic test kits consisting primarily of blood collection tubes used for nucleic acid isolation for determining the presence or absence of autoimmune and related disorders, namely, rheumatoid arthritis, fibromyalgia, and lupus
isolatefibromyalgia

General Information

Serial Number87432305
Word MarkISOLATEFIBROMYALGIA
Filing DateMonday, May 1, 2017
Status700 - REGISTERED
Status DateTuesday, June 12, 2018
Registration Number5494118
Registration DateTuesday, June 12, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkISOLATE FIBROMYALGIA
Goods and ServicesMedical diagnostic test kits consisting primarily of blood collection tubes used for nucleic acid isolation for determining the presence or absence of autoimmune and related disorders, namely, rheumatoid arthritis, fibromyalgia, and lupus

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 5, 2017
Primary Code010
First Use Anywhere DateFriday, March 16, 2018
First Use In Commerce DateFriday, March 16, 2018

Trademark Owner History

Party NameIQuity Labs, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameIQuity Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Monday, June 12, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, August 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, August 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 21, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, August 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 12, 2018REGISTERED-SUPPLEMENTAL REGISTER
Thursday, May 10, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 3, 2018ASSIGNED TO LIE
Wednesday, April 25, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, April 24, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, April 24, 2018USE AMENDMENT ACCEPTED
Tuesday, April 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 23, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, April 24, 2018AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, April 24, 2018USE AMENDMENT FILED
Monday, April 23, 2018TEAS AMENDMENT OF USE RECEIVED
Monday, April 16, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 16, 2018FINAL REFUSAL E-MAILED
Monday, April 16, 2018FINAL REFUSAL WRITTEN
Thursday, February 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 8, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 8, 2017NON-FINAL ACTION WRITTEN
Thursday, July 27, 2017ASSIGNED TO EXAMINER
Saturday, May 6, 2017NOTICE OF PSEUDO MARK E-MAILED
Friday, May 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2017NEW APPLICATION ENTERED

Related Keywords

isolatefibromyalgia autoimmune related absence presence determining disorders namely lupus fibromyalgia arthritis